These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17082659)

  • 1. CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.
    Miller AM; Lundberg K; Ozenci V; Banham AH; Hellström M; Egevad L; Pisa P
    J Immunol; 2006 Nov; 177(10):7398-405. PubMed ID: 17082659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
    Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
    Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
    Liu L; Wu G; Yao JX; Ding Q; Huang SA
    Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4+CD25high regulatory cells in peripheral blood of NSCLC patients.
    Liu L; Yao J; Ding Q; Huang S
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):548-51. PubMed ID: 17219964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus.
    Venigalla RK; Tretter T; Krienke S; Max R; Eckstein V; Blank N; Fiehn C; Ho AD; Lorenz HM
    Arthritis Rheum; 2008 Jul; 58(7):2120-30. PubMed ID: 18576316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower numbers of FoxP3 and CCR4 co-expressing cells in an elevated subpopulation of CD4+CD25high regulatory T cells from Wegener's granulomatosis.
    Klapa S; Mueller A; Csernok E; Fagin U; Klenerman P; Holl-Ulrich K; Gross WL; Lamprecht P
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):72-80. PubMed ID: 20412707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
    Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
    Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
    Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
    Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment frequency of circulating IL-17+ CD4+ T-cells, but not Tregs, correlates with clinical response to whole-cell vaccination in prostate cancer patients.
    Derhovanessian E; Adams V; Hähnel K; Groeger A; Pandha H; Ward S; Pawelec G
    Int J Cancer; 2009 Sep; 125(6):1372-9. PubMed ID: 19533748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells: implications and impact on tumor-mediated immune suppression.
    Strauss L; Bergmann C; Szczepanski MJ; Lang S; Kirkwood JM; Whiteside TL
    J Immunol; 2008 Mar; 180(5):2967-80. PubMed ID: 18292519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of CD4 + CD25 + Foxp3 + regulatory T cells in the peripheral blood and their correlation with insulin resistance in different stages of prostate cancer].
    Zhang BW; Li G; Ye JJ; Li ZR
    Zhonghua Nan Ke Xue; 2015 May; 21(5):420-3. PubMed ID: 26117939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis.
    Lan RY; Cheng C; Lian ZX; Tsuneyama K; Yang GX; Moritoki Y; Chuang YH; Nakamura T; Saito S; Shimoda S; Tanaka A; Bowlus CL; Takano Y; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 2006 Apr; 43(4):729-37. PubMed ID: 16557534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating naïve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis.
    Miyoshi H; Uchida K; Taniguchi T; Yazumi S; Matsushita M; Takaoka M; Okazaki K
    Pancreas; 2008 Mar; 36(2):133-40. PubMed ID: 18376303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
    Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.
    Muthuswamy R; Corman JM; Dahl K; Chatta GS; Kalinski P
    Prostate; 2016 Sep; 76(12):1095-105. PubMed ID: 27199259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus.
    Bonelli M; Savitskaya A; Steiner CW; Rath E; Smolen JS; Scheinecker C
    J Immunol; 2009 Feb; 182(3):1689-95. PubMed ID: 19155519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: size and diversity of CD4+CD25high Foxp3+ regulatory T cell repertoire in humans: evidence for similarities and partial overlapping with CD4+CD25- T cells.
    Fazilleau N; Bachelez H; Gougeon ML; Viguier M
    J Immunol; 2007 Sep; 179(6):3412-6. PubMed ID: 17785774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.